Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell × Bevacizumab × 30 days × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Ovarian Neoplasms 17 Carcinoma, Hepatocellular 14 Carcinoma, Non-Small-Cell Lung 13 Fallopian Tube Neoplasms 12 Neoplasms 9 Colonic Neoplasms 8 Rectal Neoplasms 6 Lung Neoplasms 6 Brain Neoplasms 6 Liver Neoplasms 5 Endometrial Neoplasms 5 Uterine Cervical Neoplasms 4 Breast Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Small Cell Lung Carcinoma 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Glioblastoma 3 Carcinoma, Renal Cell 3 Carcinoma, Pancreatic Ductal 3 Carcinoma, Ovarian Epithelial 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Lymphoid Interstitial Pneumonia 2 Gastrointestinal Neoplasms 2 Colorectal Adenocarcinoma 2 Carcinoma, Merkel Cell 2

Interventions

Cyclophosphamide 7 fludarabine 6 fludarabine phosphate 3 Specimen Handling 3 Rituximab 3 Magnetic Resonance Spectroscopy 3 zanubrutinib 2 polatuzumab vedotin 2 pirtobrutinib 2 obinutuzumab 2 glofitamab 2 Leukapheresis 2 Biopsy 2 tazemetostat 1 tafasitamab 1 pomalidomide 1 loncastuximab tesirine 1 ibrutinib 1 decitabine and cedazuridine drug combination 1 belinostat 1 axicabtagene ciloleucel 1 X-Rays 1 Vincristine 1 Prednisone 1 Pharmacokinetics 1 Pharmacogenomic Variants 1 Phantoms, Imaging 1 Nivolumab 1 MLN 8237 1 Lenalidomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡